Department of Interventional Radiology, The Hospital of the University of Pennsylvania, Philadelphia, PA, 19104, USA.
Abdom Radiol (NY). 2019 May;44(5):1901-1906. doi: 10.1007/s00261-019-01916-5.
Ascites is a relative contraindication to percutaneous biliary drainage (PBD), but patients with biliary obstruction presenting with ascites may still undergo PBD insertion. We hypothesized that ascites increases the major complication rate of PBD.
PBDs placed between January 2005 and August 2016 were identified (n = 491). Etiology and location of obstruction, the presence, and distribution of ascites based on abdominal imaging within 2 weeks of PBD, INR, WBCE, and peri-procedural complications were reviewed in the EMR.
A total of 491 PBD were placed during the study period of which 26.2% had ascites (n = 129), and 73.7% did not have ascites (n = 362). Ascites was categorized as perihepatic in 41 patients (32%), diffuse in 82 patients (64%), and non-perihepatic in 6 patients (4%). Overall, a significantly higher rate of major complications occurred in patients with ascites (19%) compared to that in patients without ascites (7.7%, P = 0.0004). Diffuse ascites was associated with a significantly higher major complication rate (26%) when compared to perihepatic ascites (7.3%, P = 0.014). In ascites patients, no association between the etiology of biliary obstruction or laterality of the PBD and the rate of major complications was identified.
The major complication rate in patients with ascites not only exceeds SIR suggested threshold of 10% but is also significantly higher than that patients without ascites. The distribution of ascites had a significant effect on complication rate, with diffuse ascites being associated with increased major complication rates compared to those with perihepatic. These findings suggest careful consideration of patients for PBD with ascites, particularly diffuse ascites.
腹水是经皮胆道引流术(PBD)的相对禁忌证,但伴有腹水的胆道梗阻患者仍可能接受 PBD 插入术。我们假设腹水会增加 PBD 的主要并发症发生率。
确定了 2005 年 1 月至 2016 年 8 月期间进行的 PBD(n=491)。在 PBD 前 2 周内,根据腹部影像学检查,在 EMR 中回顾了梗阻的病因和部位、腹水的存在和分布、INR、WBCE 和围手术期并发症。
在研究期间共放置了 491 例 PBD,其中 26.2%(n=129)有腹水,73.7%(n=362)无腹水。腹水分为肝周 41 例(32%)、弥漫性 82 例(64%)和非肝周 6 例(4%)。总的来说,有腹水的患者的主要并发症发生率(19%)明显高于无腹水的患者(7.7%,P=0.0004)。与肝周性腹水(7.3%)相比,弥漫性腹水与更高的主要并发症发生率(26%)显著相关(P=0.014)。在腹水患者中,没有发现胆道梗阻的病因或 PBD 的侧位与主要并发症发生率之间存在关联。
腹水患者的主要并发症发生率不仅超过 SIR 建议的 10%阈值,而且明显高于无腹水患者。腹水的分布对并发症发生率有显著影响,与肝周性腹水相比,弥漫性腹水与更高的主要并发症发生率相关。这些发现表明,对于有腹水的患者,特别是弥漫性腹水的患者,应仔细考虑是否进行 PBD。